Discover 1,461 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,461
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
for
Atrial Fibrillation
Location: Tacoma WA, Sacramento CA, Stanford CA,
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 70+
Code: NCT05836987
Phase 3, Recruiting
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
for
Hypogonadism, Male
Location: Tacoma WA, Seattle WA, San Francisco CA,
Sponsor: Halozyme Therapeutics
Sex: Male
Age: 12 - 17
Code: NCT06689085
Phase 3, Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
for
Stroke, PFO - Patent Foramen Ovale
Location: Tacoma WA, Portland OR, San Francisco CA,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18 - 70
Code: NCT03821129
Recruiting
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
for
Breast Neoplasms, Carcinoma, Ductal, Breast,
Location: Tacoma WA, Puyallup WA, Greenbrae CA, Stockton CA,
Sponsor: Natera, Inc.
Sex: All
Age: 18+
Code: NCT07214532
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Location: Tacoma WA, Seattle WA, Edmonton, Salt Lake City UT,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Sex: All
Age: 18+
Code: NCT04088071
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Tacoma WA, Everett WA, Portland OR, Meridian ID,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study